Significance of "de novo" appearance of thyroglobulin antibodies in patients with differentiated thyroid cancer.

Lorenzo ScappaticcioPierpaolo TrimboliFrederik A VerburgLuca Giovanella

Published in: The International journal of biological markers (2020)

Transient de novo TgAbs appearance is not infrequent during DTC patients' follow-up, and it has no apparent clinical impact. Sustained de novo TgAbs appearance is rare and may predict structural recurrences; however, similar disease-free survival was observed in patients with sustained de novo TgAbs and TgAb-negative DTC patients.

Keyphrases

end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
free survival
peritoneal dialysis
prognostic factors
computed tomography
brain injury
patient reported
subarachnoid hemorrhage
blood brain barrier
ultrasound guided